EORTC QLQ-C30 subgroup results confirm broad and durable quality-of-life improvements across disease stages and metastasis status, complementing previously reported pain reduction and opioid-free ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback